SCHEMBL25517866

SCHEMBL25517866

CCCCC(CCC1CNC1)Cn1c2ccccc2c2cc(C(=O)c3ccc(OC)cc3)ccc21

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 6/20 0.48
KDM4E B2RXH2 4/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 3/20 0.40
MAPT P10636 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
SCARB1 Q8WTV0 2/20 0.40
BACE1 P56817 1/20 0.40
CNR1 P21554 2/20 0.39
HCRTR1 O43613 1/20 0.39
LMNA P02545 1/20 0.39
RAB9A P51151 1/20 0.39
PAX8 Q06710 1/20 0.39
TSPO P30536 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25515583 0.86 CNR2 (0.56) CNR2KDM4EALDH1A1HPGDMAPT
SCHEMBL1978510 0.77 CNR2 (0.68) CNR2KDM4EALDH1A1HPGDCNR1
SCHEMBL24311554 0.76 CNR2 (0.44) CNR2KDM4EALDH1A1HPGDSCARB1
SCHEMBL24494686 0.75 CNR2 (0.61) CNR2KDM4EALDH1A1HPGDCNR1
SCHEMBL1980186 0.74 CNR2 (0.47) CNR2KDM4EALDH1A1HPGDMAPT
SCHEMBL23781994 0.74 MAPT (0.60) CNR2KDM4EALDH1A1HPGDMAPT
SCHEMBL30000178 0.74 MAPT (0.60) CNR2KDM4EALDH1A1HPGDMAPT
SCHEMBL1978626 0.74 CNR2 (0.62) CNR2KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL25515696 0.73 CNR2 (0.68) CNR2ALDH1A1HPGDSCARB1CNR1
SCHEMBL13640265 0.73 CNR2 (0.44) CNR2KDM4EALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230142648-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230142648-A1 OXIME ESTER PHOTOINITIATORS OCIAD1, OCIAD2, OXER1 CNR2 663/4885KDM4E 1857/4885ALDH1A1 964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.